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rhis has been an exciting time in congenital heart disease
CHD) because more conditions are being palliated or
epaired effectively and more adults are leading more active
nd productive lives because of their care by pediatric
ardiologists and specialists in adult CHD.
ransposition of the Great
rteries (TGA) and Congenitally Corrected
ransposition of the Great Arteries (CCTGA)
oh et al. (1) report on 45 patients who underwent the
ouble-switch. An atrial-switch plus arterial-switch proce-
ure was performed in 7 patients, and an atrial-switch plus
Rastelli-type ventriculoarterial-switch procedure was per-
ormed in 38 patients. Early mortality was 9%. Actuarial
urvival at 10 years was 78%. Six patients required conduit
eplacement, and 2 required baffle revision. Freedom from
rrhythmia was 78% at 10 years. The systemic ventricular
jection fraction was 0.57 at 1 year and 0.54 at 10 years.
hese procedures are options for CCTGA patients if their
natomy is reasonable and their left ventricle (LV) has not
eteriorated before surgery. Patients whose ventricular sep-
al defect (VSD) must to be enlarged are at risk for
orsening ventricular function. For an infant with CCTGA
nd intact ventricular septum, the investigators recommend
ulmonary banding at 5 or 6 months and then a double-
witch procedure 6 months later.
Giardini et al. (2) used cardiac magnetic resonance in 34
atients with systemic right ventricles (RVs): 23 with atrial
epair for TGA and 11 with CCTGA. The mean age was
5 years: late gadolinium enhancement (LGE) was present
n 41% of cases and was associated with older age, lower
ight ventricular ejection fraction, higher wall stress, re-
uced oxygen uptake, and arrhythmia. Twelve patients had
orsening of their condition associated with decreases in
iventricular function and increases in the prevalence of
GE. Cardiac magnetic resonance can be useful in follow-
ng up patients with systemic RVs, particularly when con-
idering double-switch versus transplantation when func-
ion deteriorates.
rom the Division of Pediatric Cardiology, Vanderbilt Children’s Hospital, Nashville,
ennessee.c
Manuscript received March 12, 2007; revised manuscript received April 3, 2007,
ccepted April 10, 2007.Fratz et al. (3) present data showing that myocardial scars
re not common in systemic RVs. These investigators
tudied 18 patients with TGA after atrial-switch and 9
CTGA patients without surgery. Only 1 patient had an
GE scar; positron emission tomography showed no scars.
ne reason for the difference between these studies and
revious ones is that these patients underwent surgery at a
ounger age and had less time for development of scars
efore surgery. They suggest that some of the previous
tudies had overzealous interpretation of abnormal perfu-
ion or LGE. Another possibility is that their patients were
ounger, and only 2 of 9 CCTGA patients and 4 of 18
GA patients had an ejection fraction 40%. There is
rogressive deterioration of RV function, which might be
elated to abnormal scars in patients with systemic RVs;
ost show minimal deterioration of function in their 20s
ut progressive deterioration with increasing age, particu-
arly in the 4th to 6th decades.
Lange et al. (4) reported on 417 TGA patients after
trial-switch surgery. Survival was 76% for the Mustard
peration and 91% for the Senning procedure at 25 years.
atients in the Mustard group died more often from
rrhythmia than patients in the Senning group and needed
ore baffle reoperations. A VSD closure at the time of
peration and the Mustard operation were independent risk
actors for late mortality; 86% of the patients led a normal
ife with full-time work, and 12% did part-time work. This
epresents the “glass half full” for atrial-switch procedure
atients rather than “half empty.” Although the results look
easonably good, RV dysfunction was present in 16% at
5-year follow-up. The Senning procedure was performed
t a time when myocardial protection was probably consid-
rably better than with the Mustard procedure. Finally,
ystemic RV dysfunction is more likely to happen in the 4th
r 5th decade than in the 2nd or 3rd decade. Nevertheless,
his report is encouraging, and hopefully these patients will
ontinue to lead active and productive lives with current
anagement strategies.
Rouine-Rapp et al. (5) studied 29 neonates undergoing
n arterial-switch procedure to determine whether segmen-
al wall motion abnormalities indicate myocardial ischemia.
ntraoperative transesophageal echocardiography readings
ere recorded at baseline and after bypass. The transtho-
acic echocardiography readings were obtained before dis-
harge. Segmental wall motion was normal in 9 neonates
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July 24, 2007:368–77 Year in Congenital Heart Diseasend abnormal in 20 early postbypass. Abnormalities were
ersistent at chest closure in 15 of 20 neonates. There was
lectrocardiographic evidence of ischemia in 2 of 9 with
ormal wall motion, 1 of 5 with transient wall motion
bnormalities, and 9 of 13 with wall motion abnormalities at
hest closure. Troponin levels at 12, 24, and 48 h and
ntraoperative segmental wall motion abnormalities were
redictive of postoperative abnormalities. There were no
eaths. Most of these patients do well despite transfer of
oronary vessels with significant intraoperative ischemia of
1 h. The fact that more of them do not have segmental
all motion abnormalities can be attributed to the surgical
kills of our colleagues and improved myocardial protection.
t is important to follow up these patients to determine
hether wall motion abnormalities persist and whether they
re associated with structural or functional coronary abnor-
alities, arrhythmia, and/or ventricular dysfunction.
Losay et al. (6) reported on aortic regurgitation (AR)
fter arterial switch for TGA in 1,156 hospital survivors. At
6 months, 15% had AR. Complex TGA, prior pulmonary
anding, arch anomalies, AR at discharge, older age at
witch, and aortic/pulmonary size discrepancy were associ-
ted with AR. Freedom from AR was 70% at 15 years.
eoperation for AR was performed in 16 patients with 1
eath. Freedom from reoperation for AR was 97% at 15
ears and slowly increased from 2 years to 16 years. Aortic
egurgitation is uncommon in terms of significant volume
verload. Unfortunately, it is present in some and may
equire late surgery.
Bautista-Hernandez et al. (7) reported on aortic root
ranslocation plus arterial switch for TGA with LV outflow
bstruction in 11 children ages 1 month to 11 years. The
ortic root was excised and inserted in the LV outflow tract,
nlarging it by resecting the outlet septum and putting in a
atch. After coronary reimplantation, RV outflow recon-
truction was achieved with a homograft (see Figs. 1 to 4 in
autista-Hernandez et al. [7]). There were no deaths with
ollow-up of 59 months; 5 patients required 6 conduit
eplacements at a median of 53 months. Two patients
equired implantable defibrillators, and none have devel-
ped LV outflow obstruction. The investigators advocate
his approach when the pulmonary valve is dysplastic or
ven bicuspid, the pulmonary annulus is abnormally small,
nresectable pulmonary stenosis is present, and/or a strad-
ling tricuspid valve is associated with a small RV. It
equires a long cross-clamp time but can be useful in the
onditions indicated. It could become the procedure of
hoice for TGA and LV obstruction if it can be performed
ith equal or improved morbidity and mortality as the
tandard Rastelli procedure.
etralogy of Fallot (TF)
hong et al. (8) reported on aortic root dilation in 67
hildren after repair of TF. Aortic dilation defined as a
-score2 was found in 88% at the annulus and 87% at the sinus. Duration of follow-up was the only determinant of
ilation; AR was present in 12% of patients who had larger
imensions at all aortic levels. These patients had increased
ortic stiffness and reduced strain and distensibility. A TF
epair was performed at 3 years on average, and despite
elatively early correction, the cases show progressive aortic
ilation. I have considered aortic dilation after TF repair to
e caused by the large right-to-left shunting occurring over
any years before repair. Dilation can continue after repair
espite having right-to-left shunting with high systemic
utput for a relatively short period of time preoperatively.
his may program the aorta for progressive dilation. For-
unately, severe aortic root dilation and AR are uncommon
ith childhood repair, and aortic aneurysm with dissection
as not been reported to my knowledge.
Laudito et al. (9) reported on 112 patients younger than
months of age who underwent repair of TF or truncus,
ith an atrial septal defect (ASD) left in 80. In patients with
n ASD, mean oxygen saturation reached a nadir of 94%
nd mean arterial pO2 a nadir of 73 mm Hg at 16 to 24 h;
oth increased during the second 24 h. At hospital dis-
harge, median saturation was 98% (range 86% to 100%).
ean right atrial pressure was 10 mm Hg in 30 patients
nd was associated with older age and transannular patch.
linically significant desaturations were rare. Infants 2
onths of age are at higher risk for desaturation. Leaving an
nteratrial communication to provide a “pop-off” if RV
ressure and/or distensibility is increased after TF repair has
een done for many years. Occasionally, patients will have
esaturation significantly early, or on occasion, late postop-
ratively with changes in RV diastolic properties and/or
rogressive pulmonary regurgitation. These investigators
tate that if the patent foramen ovale was larger than 4 to 5
m, it was partially closed to 4 to 5 mm. The question
emains regarding which patients require this for a smooth
ostoperative course. Having to go back and close these
efects with an interatrial device is relatively easy now, but
would hope that it could be avoided in the majority of
atients if one could come up with an algorithm for when to
eave a small ASD.
Airan et al. (10) reported on 860 patients ages 6 months
o 40 years undergoing correction of TF, with 334 consid-
red suitable for transatrial repair. Perioperatively, 30 pa-
ients required right ventriculotomy and transannular patch
nd were excluded. In addition, pulmonary arteriotomy was
equired in 71 patients. There were 4 hospital deaths and 4
arly reoperations for residual/additional VSD in 3 and
ricuspid regurgitation in 1. Two patients had complete
eart block. Echocardiography at discharge showed a peak
V outflow gradient of 20 mm Hg and was reduced to 13
m Hg after an interval of 19 months. In 300 cases (90%),
easibility of transatrial repair could be predicted accurately.
atients were referred at a later age and only 10% of these
atients had a prior shunt, indicating that these were not the
evere TF patient needing infant surgery. Contraindications
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Year in Congenital Heart Disease July 24, 2007:368–77o this procedure are the need for pulmonary root enlarge-
ent or pulmonary arterioplasty.
Bockeria et al. (11) report on TF repair with unilateral
bsence of the left pulmonary artery in 25 and the right in
patients. Twenty patients underwent palliative procedures
ncluding aortic root pulmonary shunts, transluminal pul-
onary valvuloplasty, and reconstructive RV outflow tract
ithout VSD closure. At a median of 3.6 years after
alliation, 13 patients underwent complete repair and 7 had
rimary repair. Mortality after palliation was 1 in 20 or 5%,
nd mortality after repair was also 1 in 20 or 5%. These
nvestigators suggest that a Nakata index 200 mm2/m2
nd z-score 4 are criteria for successful repair. If the
ndex is less, these patients should have palliation before
epair. This is a rare condition, and obviously one hopes that
diagnosis can be made early in life and that the pulmonary
rtery, which may be isolated with a ductus, can be salvaged
o that repair to both lungs can be performed.
Amark et al. (12) report on factors associated with
ortality, reintervention, and achievement of complete
epair in TF with pulmonary atresia. Of 220 children
resenting to their institution, a total of 185 underwent
urgery and repair was definitive in 75%. Initial procedures
ere systemic pulmonary artery shunts in 57%, complete
rimary repair in 31%, and RV outflow tract reconstruction
n 12%. Based on angiography, 118 patients had simple
ulmonary atresia and 53 had major aortopulmonary collat-
ral vessels. Survival from the initial procedure was 71% at
0 years. Risk factors for death after this procedure included
ounger age, earlier birth cohort, and fewer bronchopulmo-
ary segments supplied by native pulmonary arteries and
nitial placement of a systemic pulmonary artery shunt.
ompeting risk analysis for initially palliated patients pre-
icted after 10 years that 68% achieved complete repair,
2% died without repair, and 10% remained alive without
epair. Reoperations after repair occurred in 27%, with risk
actors including older age at palliation, major aortopulmo-
ary collateral arteries, and more segments supplied by
ollateral vessels. Outcome improved with time and was
etter in completely repaired cases. The difficult patients in
his group are those with major aortopulmonary collateral
rteries, of which there were 53. Of these, 24 were dead
fter no intervention, without reaching repair or after staged
epair. The push for an early primary procedure or at least
V outflow tract reconstruction for those whose central
ulmonary arteries are small or absent continues to be the
reatment of choice for many centers. Hopefully this group
f patients will continue to show improved outcome with
he new techniques as emphasized by Reddy et al. (13).
ypoplastic Left Heart
hanayem et al. (14) reported on randomization to either
he RV–pulmonary artery conduit or a Blalock-Taussig
BT) shunt as initial palliation of hypoplastic left heart
yndrome (HLHS) patients. There were 1 early and 1 late 4eath in the conduit group and 1 interstage death in the
hunt group. Diastolic blood pressure was lower in the shunt
roup, but there were no differences in arterial saturation,
enous oximetry, mean blood pressure, and pulmonary/
ystemic flow ratio between groups. These 2 types of
alliation for the first stage of HLHS palliation are associ-
ted with similar results by experienced teams. There is a
andomized study being performed with a larger number of
atients, and hopefully it will answer more definitively the
uestion of whether one type of palliation has a more
avorable outcome in different HLHS subtypes. These
nvestigators believe that the use of phenoxybenzamine is
mportant for afterload reduction in both the conduit and
he shunt procedures.
Jaquiss et al. (15) reported on early superior cavopulmo-
ary anastomosis (SCPA) after stage I procedure in 85
atients with HLHS. Patients were divided into group 1
ith SCPA at 4 months (33 patients), and group 2 with
CPA at 4 months (52 patients). Sixty-nine patients have
ndergone Fontan procedures, 7 await Fontan procedures, 1
nderwent transplantation, 3 are not Fontan candidates,
nd 5 died late. Group 1 and group 2 patients who had a
ompleted Fontan procedure were compared for preopera-
ive and postoperative variables. There are no differences in
hese variables or late functional assessment, and actuarial
urvival at 6 years was not different. Although initially more
yanotic and hospitalized longer, younger SCPA patients
chieved clinical equivalence for the Fontan procedure and
fterward. These data support performance of early SCPA
o try and prevent interstage mortality.
Li et al. (16) reported on the adverse effects of dopamine
n systemic hemodynamic status and oxygen transport in
LHS after the Norwood procedure. Systemic oxygen
onsumption was continuously measured in 13 sedated,
aralyzed, and mechanically ventilated neonates for 72 h
fter the Norwood procedure. Terminating dopamine was
ot associated with changes in arterial pressure, Qp/Qs, or
xygen delivery. Dopamine induces increasing VO2 in
eonates after the Norwood procedure; termination is
ssociated with improved VO2 and oxygen transport bal-
nce. These data emphasize the need for cautious manage-
ent in the use of inotropes, particularly dopamine, in these
ragile infants.
Gruber et al. (17) reported results of single-stage biven-
ricular repair of severe aortic hypoplasia or atresia in 21
nfants with VSD and normal LV. Aortic atresia was
resent in 7 patients, aortic stenosis in 14 patients, and 6
atients had interrupted arch. All patients with aortic
tenosis had annular diameters 3 mm or smaller. Circulatory
rrest time was 55 min; cross-clamp time was 56 min.
n-hospital survival was 100%, with 1 late death. There was
o significant outflow tract obstruction; total stay was 17
ays. Reoperation was necessary in 10 cases, with leaks in
he VSD baffle common. The ASD was downsized to 2 to
mm in all patients.
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July 24, 2007:368–77 Year in Congenital Heart DiseaseThis is an outstanding result in this patient group;
oncardiac anomaly or genetic syndrome did not contribute
o mortality or morbidity.
ontan
eyer et al. (18) report on outcomes of the Fontan
rocedure using cardiopulmonary bypass with aortic cross-
lamping in 160 patients with a mean age of 2.2 years;
LHS was present in 71% and heterotaxy in 12%. Aortic
ross-clamping was used in 96% and deep hypothermic
irculatory arrest in 83%. A lateral tunnel Fontan was used
n 43% and an extracardiac Fontan in 57%: fenestration was
sed in 90%. Freedom from death or take-down was 98%.
edian duration of pleural drainage was 2 days. Median
uration of hospitalization was 6 days (range 3 to 55 days).
ome investigators have suggested that the management
trategy should be to avoid bypass and cross-clamping in
hese patients to prevent the consequences of bypass and
erioperative myocardial dysfunction. The Fontan proce-
ure completed the old-fashioned way can be performed
ith outstanding results.
Giannico et al. (19) report on the clinical outcomes of 193
xtracardiac Fontan patients. There were 165 of 193 early
urvivors who underwent noninvasive follow-up and at least
catheterization. The overall survival was 85% at 15 years.
reedom from late failure among hospital survivors was 92%
t 15 years. The incidence of late major problems was 24%;
1% had arrhythmias, 3% had obstruction of conduit, 3.5%
ad left pulmonary artery stenosis, and 3% experienced
entricular failure leading to heart transplantation in 3 of 5.
rotein-losing enteropathy was found in 2 patients, and 4
atients died late, 2 after transplantation. Functional status
nd cardiopulmonary performance was excellent. The inci-
ence of late death, obstructions of the cavopulmonary
athway, is lower than that reported after other Fontan
perations, although follow-up is not as prolonged. Ob-
truction of the conduit remains a potential long-term
roblem. There were 36 patients with more than 10 years of
ollow-up, and conduit obstruction developed in only 5. The
echanism of obstruction was longitudinal torsion during
apid growth. Cardiac magnetic resonance data showed no
ecreasing diameter after 6 months. This is good news if it
an be repeated in other patients; the conduit story has not
een so happy when used in other situations.
Fiore et al. (20) report on a comparison of lateral tunnel
ith extracardiac conduit in 162 patients, 49 extracardiac
onduit and 113 lateral tunnel. Extracardiac conduit pa-
ients were older and had a higher frequency of heterotaxy
yndrome, and lateral tunnel a higher frequency of HLHS.
reoperative saturation, rhythm, diastolic pressures, and
ranspulmonary gradient were similar. Cardiopulmonary
ypass was similar, but fewer extracardiac conduit patients
eeded aortic cross-clamping. Fenestrations were more
requent in lateral tunnel cases, 73% versus 16%. Operative
ortality was 1.8% overall and not different between groups. sn addition, there were no differences in transpulmonary
radient, readmission for effusion, and changes in ejection
raction relative to preoperative level. Resource use was
igher in the extracardiac group; loss of sinus rhythm and
requency of all neurological events did not differ. There
ere 7 late deaths equally distributed between groups.
ctuarial survival at 5 years was not different; 90% for
xtracardiac, 95% for lateral tunnel patients. It seems that
ou can do quite well with either operation. As one of the
iscussants says, “it is best to tailor the operation to patient
nd not try to tailor the patient to the operation.”
Tatum et al. (21) report on pulmonary artery growth after
ontan procedure. Sixty-one children who underwent a
odified Fontan procedure at a median age of 53 months
nd had angiography for assessment of pulmonary size
efore and during follow-up were studied. An atriopulmo-
ary connection was present in 23 patients, and total
avopulmonary connection was present in 38 patients.
ostoperative angiograms were performed at a median of 19
onths after Fontan procedure. The growth of each artery
as measured just before the first branching point. The
rowth of pulmonary arteries failed to match the increase in
ody surface area in the majority of patients. It is speculated
hat poor pulmonary artery growth may be a factor in late
ontan procedure failure. Hopefully most patients in the
rst 3 to 4 months before their bidirectional cavopulmonary
nastomosis will have enough antegrade flow or shunt flow
o give them adequate-sized pulmonary arteries so that this
ill be less of a long-term factor. Patients with large
ulmonary arteries tend to sail through their Fontan pro-
edure with good midterm results.
Senzaki et al. (22) report on 17 Fontan procedure patients
ith good functional status and 20 patients with normal
-ventricle circulation serving as a control group in whom
hey examine changes in contractility, diastolic function,
nd loading factors at rest, with atrial pacing and beta-
drenergic stimulation. At baseline, Fontan procedure pa-
ients showed minimum abnormalities of cardiac properties,
ut an increase in afterload resulted in decreased cardiac
ndex. In addition, Fontan circulation was associated with
imited inotropic response and worsening of diastolic filling
ith increased heart rate leading to decreased systolic
ressure and elevation of central venous pressure. Further-
ore, beta-adrenergic reserve was markedly decreased in
atients owing to limited preload reserve. These studies
how abnormalities that have been associated with exercise
n adults with congestive heart failure. Improvements in
rognosis after Fontan procedure may require development
f medical interventions that can overcome limitations that
re inherent in the Fontan circulation.
Backer et al. (23) reported on results of conversion of the
ailed Fontan circulation in 78 patients and transplantation
n 8 patients because of failure of the Fontan circuit, with 4
f 8 having failed attempted conversion. Surgical techniques
onsist of excision of the dilated right atrium, arrhythmic
urgeries, 24-mm extracardiac conduit placed at the inferior
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Year in Congenital Heart Disease July 24, 2007:368–77aval vein to the pulmonary arteries, bidirectional SCPA,
nd epicardial pacemaker. There were 1 early and 3 late
eaths. In addition, the investigators highlight previous
tudies indicating an overall early mortality of 2% and late
ortality of 4% for this procedure. For cardiac transplanta-
ion, 60-day mortality is 27%. Obviously transplantation
atients were much more symptomatic. One of the most
hallenging aspects of dealing with a failing Fontan proce-
ure is when to go for conversion and when to go to
ransplantation.
Bernstein et al. (24) report on the outcome of listing for
ardiac transplantation for failed Fontan procedure with a
ulti-institutional review of 97 Fontan procedure patients
18 years of age. The mean age at listing was 9.7 years,
ith 25% 4 years. Pretransplantation survival was 78% at
months and 74% at 12 months, and was similar to that for
43 children with other congenital heart disease (CHD) and
47 children without CHD. At 6 months the probability for
eceiving a transplant was similar for status 1 and 2; however,
he probability of death was higher for status 1 (22% vs. 5%).
eventy patients underwent transplantation, and survival was
6% at 1 year and 68% at 5 years, slightly less than CHD and
o CHD patients. The cause of death included infection in
0%, graft failure in 17%, rejection in 13%, sudden death in
3%, and graft coronary artery disease in 9%. Protein-losing
nteropathy resolved in all 34 who survived 30 days. Heart
ransplantation is an effective therapy for pediatric patients
ith a failed Fontan procedure, midterm results are encourag-
ng, and protein-losing enteropathy can be expected to resolve.
his represents excellent continued palliation for those patients
ho have failed the last stage repair for their single-ventricle
alformation.
alvular Disease
uzmetov et al. (25) presented data on 147 patients ages 10
ays to 18 years who underwent aortic valve replacement.
verall, early and late mortality was 7.5%, and survival was
stimated at 93% at 20 years. Date of procedure was a risk
actor for death, and follow-up was completed in 136.
alve-related reoperation rate was 20%. Reoperation rate
as highest in the xenograft group, followed by mechanical
alves, homograft, and the Ross procedure. Ross procedure
atients show significant increases in aortic annulus and
inus diameter at last follow-up. The potential for develop-
ent of significant autograft insufficiency and ascending
ortic aneurysmal dilatation is small but warrants annual
ollow-up. These investigators support the Ross procedure
s the procedure of choice for children. Patients who have
rogressive dilation of the aortic root and require reopera-
ion represent a challenging surgical procedure. Fortunately,
hese patients are rare and usually are those with severe AR
efore surgery. Whether or not the pulmonary root in these
atients (who most likely had bicuspid aortic valves) are
tructurally similar and prone to progressive dilatation is
nclear. iReemtsen et al. (26) reviewed 16 neonates with profound
eart failure caused by the Ebstein anomaly. Indications for
urgery were overt heart failure, cyanosis, and acidosis
ssociated with tricuspid regurgitation, depressed RV func-
ion, and severe cardiomegaly. The strategy was first to
ssess the possibility for repair with or without RV outflow
ract reconstruction. If this was not feasible, RV exclusion
as performed by oversewing the tricuspid valve with a
atch. A reduction atrioplasty was performed, and depend-
ng on the extent of the atrialized portion of the RV,
lication was performed. A modified BT shunt provided
ulmonary flow. The univentricular approach evolved to
nclude a fenestration in the tricuspid valve patch to allow
or RV decompression. Tricuspid valve repair was under-
aken in 3 patients, with 1 requiring conversion to RV
xclusion 3 months after the initial operation. In those with
V exclusion, the tricuspid patch was fenestrated in 10 of
3. One patient had heart transplantation as the initial
rocedure. There were 5 hospital deaths and no late deaths.
urvival of the cohort with a fenestrated tricuspid valve
atch was 80%, versus 33% for the nonfenestrated group.
urgeries including homograft placement in the RV outflow
ract, whether during repair or during RV exclusion, ended
n death. These investigators conclude that RV exclusion
ith a fenestrated tricuspid valve patch, reduction right
trioplasty, plus a BT shunt have provided effective pallia-
ion for neonates presenting with critical Ebstein anomaly
nd a valve that cannot be repaired.
It is frequently difficult to decide whether or not a
-ventricle repair is feasible. If the patient has a tripartite
V with open RV outflow tract, the investigators attempt to
epair the valve; otherwise they would go to RV exclusion.
hey also make it clear that they attempt to stabilize these
atients and not to perform surgery on neonates.
Guleserian et al. (27) reported on the natural history of 32
atients with pulmonary atresia with intact ventricular
eptum and RV-dependant coronary circulation managed
y the single-ventricle approach. All underwent initial
alliation with a modified BT shunt. The median tricuspid
alve z-score was3.62, and all had moderate or severe RV
ypoplasia. The median follow-up was 5 years, and mortal-
ty was 19%, with all deaths occurring within 3 months of
hunting. Aortocoronary atresia was associated with 100%
ortality in 3 patients. Of the survivors, 19 have undergone
Fontan procedure, whereas 7 have received a bidirectional
lenn shunt, awaiting a Fontan procedure. Actuarial sur-
ival was 81% at 15 years. No late mortality occurred among
hose surviving beyond 3 months. These patients’ early
ortality seems related to coronary ischemia at the time of
T shunt. Those with aortocoronary atresia should undergo
ransplantation. It is sometimes difficult to determine
hether the patient is entirely dependant on RV pressure
or coronary circulation. These investigators defined it by
ither the presence of ventriculocoronary fistulae with an-
iographically severe obstruction of 2 major coronary arter-
es, complete coronary atresia, or situations in which a
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July 24, 2007:368–77 Year in Congenital Heart Diseaseignificant portion of LV was supplied by the RV and was
udged at risk for ischemia with RV decompression or
linical deterioration with ischemia on RV decompression.
uring bypass, the RV must be kept filled, or there will be
educed coronary perfusion with ventricular dysfunction.
hey used cardiopulmonary bypass at the time of bidirec-
ional Glenn and Fontan procedures with adequate RV
lling and contraction maintained. They do not use cardio-
ulmonary bypass during shunt construction.
Beroukhim et al. (28) reported on the progression of
ortic dilation in 101 children with isolated bicuspid aortic
alve and no hypertension, or any syndrome, and compared
ata with 97 control patients. Mean age was 9 years, and
as not different between patients and control patients.
atients had larger aortic dimensions in all regions of the
orta, with the most striking discrepancy in the ascending
orta. The size discrepancy was present from birth and
ersisted throughout childhood. Patients had significantly
reater increases in ascending aorta dimension than control
atients per year of follow-up. Bicuspid aortic valve is
omplicated by progressive aortic dilation beginning in
hildhood.
Beroukhim et al. (29) also studied patients with isolated
icuspid aortic valve compared with patients with Marfan
yndrome. Patients with bicuspid valve had greater dilation
han those with Marfan syndrome at the ascending aorta,
ith dilation often extending cranially beyond the region of
easurement. Conversely, patients with Marfan syndrome
ad more focal dilation at the sinuses of Valsalva compared
ith control patients. This difference in patterns of dilation
s important in terms of the measurements that are ob-
ained. Surgical recommendations for the Marfan group
ay not be applicable to the bicuspid valve group given the
ifferent sites and degrees of dilation. Although aneurysmal
ilation of the ascending aorta certainly occurs with isolated
icuspid aortic valve, dissection and/or rupture is rare given
he almost 1% prevalence of the anomaly in the population.
Ciotti et al. (30) compared 117 patients with bicuspid
ortic valves and 62 patients with bicuspid valves plus
oarctation. The median age of patients with bicuspid aortic
alve was 4 years, and with coarctation was 1.9 years.
icuspid aortic valves with right/left cusp fusion were
ignificantly associated with coarctation and cardiac anom-
lies, whereas valves with noncoronary/right cusp fusion
ere affected by valvular dysfunction. Compared with nor-
al tricuspid valves, bicuspid valves had aortic root dilation,
ven in children with no hemodynamic disturbance. The
ifference is still significant comparing bicuspid and tricus-
id valves with coarctation. Although detectable early in
ife, valvar dysfunction and aortic root dilation progress
ith age.
Canna et al. (31) reported on adults with ascending aortic
ilation with normally functioning bicuspid and tricuspid
ortic valves. These investigators performed transesophageal
chocardiography 12 months apart in 113 patients, with
7 having bicuspid valves and 86 having tricuspid valves fith aortic diameters of 40 to 60 mm and no significant
ortic stenosis or AR. Diameters of the sinuses of Valsalva,
he sinotubular junction, and the tubular tract were similar
n both groups. During 3-year follow-up, the rate of
scending aorta diameter progression was similar for the
icuspid and tricuspid valve groups. Three patients in the
ricuspid valve group experienced cardiac death, 2 died
uddenly, and 1 died after surgery for aortic dissection.
here was no occurrence of cardiac death in the bicuspid
alve group. In conclusion, the rate of progression of
scending aortic aneurysms was similar in patients with
icuspid valves versus those with tricuspid valves. Further-
ore, patients with bicuspid valves did not have increased
ates of aneurysm-related complications compared with
atients with tricuspid valves. After reading all 4 of these
tudies, several things seem to be clear: children with
icuspid aortic valves have larger aortas in the ascending
rea than patients with tricuspid valves, even without
ssociated defects or hypertension. The progression of the
ilation in young patients seems to be greater in bicuspid
alves than with other groups. Patients with coarctation
ave a particular type of bicuspid valve and are prone to
ilation. Ascending aortic aneurysms with rupture are ex-
eedingly rare, but when an adult has an aortic root that is
ignificantly dilated, it will progress at the same rate as those
ith tricuspid aortic valves and not at a greater rate.
It is still unclear what to do with the asymptomatic
atient whose aortic root is dilated to 5 cm. Certainly, with
ny valvular surgery that is needed, aortic root replacement
r some type of procedure to try to protect against future
neurysmal dilation and dissection should be performed. If
atients do not have hypertension, the conservative ap-
roach may be useful, but patients should be followed up
losely and any rapid progression in dilation or questionable
ymptoms should be a signal for consideration for root
eplacement. Cardiac magnetic resonance studies can be
elpful in this regard.
nterventional Catheterization
zkutnik et al. (32) reported on the use of the Amplatzer
uscular VSD occluder (AGA Medical Corp., Golden
alley, Minnesota) for closure of perimembranous VSDs in
0 patients, ages 3.2 to 40 years. These VSDs had a mean
iameter of 5.4 mm with extension toward the muscular
eptum; mean distance from the aortic valve was 5.4 mm in
ll but 1 patient. All procedures except 1 were performed
ithout complication, and complete closure was achieved.
ne patient had a residual shunt with hemolysis, which
esolved after 10 days. Trivial tricuspid regurgitation ap-
eared after the procedure in 3 patients. No other compli-
ations were observed in follow-up from 0.2 to 3.5 years.
hese investigators resorted to a muscular VSD occluder in
hese patients because of previous problems with heart block
sing the asymmetric septal occluder, which was designed
or the perimembranous VSD. One wonders why the
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Year in Congenital Heart Disease July 24, 2007:368–77ajority of these small VSDs were closed: 7 had VSDs 4.5
m or less and cannot have had significant LV volume
verload at the ages reported. In most centers, these cases
ould not have been sent for surgery or for interventional
losure.
In an accompanying editorial by Sullivan (33), there is an
xcellent review of VSD closure. Interventional closure of
erimembranous VSD is rarely performed in the United
ingdom currently, and the suggestion is that all patients be
ubmitted to a registry when this is done. The incidence of
eart block in one registry in Europe is 5% or 13 of 250
ndergoing closure of perimembranous VSD; 4 of these
ere transient but 9 were permanent, occurring late after
SD closure in 4 of these patients. Sullivan also reports that
t the Great Ormond Street Hospital, incidence of com-
lete heart block occurring after surgical closure of VSDs
as 7 of 996 patients (0.7%). In summary, small VSDs do
ot warrant closure with a device when there is no LV
olume overload or other indication for surgical closure such
s a prolapsing aortic valve cusp. In addition, patients who
re having perimembranous VSDs closed with a device
hould be reported to a registry so that accurate data can be
btained and the risks and benefits known.
Mullen et al. (34) reported a prospective, multicenter
tudy of 58 patients ages 28 years to 68 years with a clinically
ignificant ASD or patent foramen ovale who had percuta-
eous shunt closure with a new bioabsorbable ASD implant.
uccessful implantation was achieved in 98% (57 of 58
atients). Closure at 30 days and 6 months was 92% and
6%, respectively. There was no evidence of a clinically
ignificant response to the device. Transient atrial arrhyth-
ia occurred in 5 patients after implantation. No major
afety issues were observed. This is a novel implant designed
o provide biological closure of atrial-level defects using the
atural healing response; 90% to 95% of the implant is
bsorbed and replaced with native tissue, and future access
o the left atrium may be achieved when needed. This is a
otentially outstanding breakthrough.
Aggarwal et al. (35) reported on 28 of 31 patients who
nderwent stent placement for palliation of RV pulmonary
rtery conduit stenosis. The RV/systemic pressure ratio
ecreased from 0.75 to 0.52, and conduit diameter increased
rom 9 to 12 mm in one view and 8 to 12 mm in the
rthogonal view. In patients with successful placement, 29%
ere free from a second intervention. In the remaining
atients, the median time to reintervention was 16 months
range 6 to 44 months). Second interventions were success-
ul in 8 of 13 patients. Complications included balloon
upture in 4, stent fracture in 2, and pseudoaneurysm
ormation in 1. If there is a coronary vessel crossing the RV
utflow tract, one must do test balloon dilation to be sure
oronary ischemia does not occur before stent placement.
onduits continue to be problematic, and stent palliation
ay be useful in patients before surgery.
Coats et al. (36) reported on relief of RV outflow tractbstruction in 18 patients with percutaneous valve implan- eation. All had a gradient 50 mm Hg without important
ulmonary regurgitation. The RV gradient decreased from
1 to 22 mm Hg, and RV pressure from 73 to 47 mm Hg.
xercise capacity improved, as did RV and LV ejection
raction. This more physiological treatment of conduit
bstruction is hopeful in terms of palliation. How long it
ill last and whether it will be difficult to remove surgically
n the future remain unclear.
Agnoletti et al. (37) reported on 15 patients with right-
o-left ASD shunt after repair of complex conditions.
ercutaneous ASD closure was performed with exercise
ests before and after. Five patients were cyanotic at rest,
nd during exercise saturations ranged from 94% to 84%.
he ASD closure led to an increase in saturation from 94%
o 99%, and at 3 years, all but 1 patient with a residual ASD
ad normal saturations during exercise. Maximum workload
ncreased from 7 to 9 metabolic equivalents. These defects
an be troublesome long-term, and some patients develop
nough cyanosis to limit their exercise capacity. In such
atients, device closure seems reasonable.
Tzifa et al. (38) reported on use of covered stents for
oarctation as a rescue treatment in patients with aneurysm
r previous stent-related complications and patients at risk
or developing complications because of complex anatomy
r advanced age. Thirty-three stents were implanted in 30
atients (range 8 to 65 years); 16 patients had previous
rocedures. The systolic gradient decreased from 36 to 4
m Hg after the procedure, and the diameter of coarctation
ncreased from 6 to 17 mm. The follow-up period was 40
onths (mean 11 months). All stents were patent and in
ood position on computed tomography or cardiac magnetic
esonance imaging 3 to 6 months later. In 43%, antihyper-
ensive medication was decreased or stopped (see Figs. 1 to
in Tzifa et al. [37]). This is a good rescue treatment for
atients with complicated anatomy or previous aneurysms.
opefully it can be shown to have significant longevity.
Carr (39) reports on a review of endovascular stenting and
ngioplasty versus surgery for adult coarctation. The imme-
iate improvements in hypertension and the morbidity were
imilar across groups. Surgery was associated with a low risk
f restenosis or recurrence, whereas endovascular therapy
ad a higher incidence of restenosis and repeat intervention.
his is an interesting report from a surgeon. It should be
lear that this review is not comparing apples to apples. To
ave a true comparison, the complexity of coarctation and
revious complicating features would have to be similar in
he 2 groups. Nevertheless, this is interesting reading, and
erhaps there will be a review by interventionalists in the
uture. When considering therapy for an adult with coarc-
ation or recoarctation, the details of the anatomy and the
kill and experience of both the surgeon and intervention-
lists must be considered in terms of management.
Ou et al. (40) reported on the effect on blood pressure of
ortic shape deformation after coarctation surgery. They
tudied normotensive patients with repair by simple or
xtended end-to-end anastomosis. All patients had exercise
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July 24, 2007:368–77 Year in Congenital Heart Diseasetudies and cardiac magnetic resonance imaging. Three
ypes of aortic arch geometry were evident: Gothic arch with
ngular geometry and an increased height-to-width ratio in
he arch, Crenel arch with a rectangular arch shape, and
ormal arch with a smooth rounded shape. Exercise-
nduced hypertension was more frequent in patients with
othic arch, with a prevalence of 83% at 15 years after
urgical intervention versus 25% in those with Crenel and
1% of those with normal arch geometry. The cumulative
ncidence of exercise-induced hypertension was higher in
atients with Gothic arch through follow-up. This provoc-
tive study shows why some patients who have normal
lood pressure differences between arms and legs at rest and
o anatomical narrowing of any significance on cardiac
agnetic resonance angiography develop hypertensive
pper-extremity blood pressure with exercise. Whether this
ype of architecture can be avoided with certain surgical
odification is unclear, but hopefully there will be innova-
ive surgeons who will find ways to improve the architecture.
dult CHD
arelli et al. (41) studied the prevalence of CHD in
uebec, Canada, where each individual is assigned an
dentification number by age 1 year. The prevalence of
HD was determined in 1985, 1990, 1995, and 2000.
hildren were defined as 18 years of age and adults as
18 years old. The prevalence was 4.09 per 1,000 adults in
he year 2000 and 0.38 per 1,000 for those with severe
esions. The median age of all patients with severe CHD
as 11 years in 1985 and 17 years in 2000. The prevalence
f severe CHD increased from 1985 to 2000, but the
ncrease in adults was higher than in children. In the year
000, 49% of those with severe CHD were adults. This
tudy indicates the changing of the guard in terms of the
umber of patients with CHD. Adult patients outnumber
ediatric patients, and more and more adult specialists will
eed to be taking over their care each year as more
pecialists are trained to do so.
Rossano et al. (42) retrospectively reviewed patients 18
ears old who underwent cardiac surgery at a pediatric
nstitution. There were 149 operations in 135 patients, with
early deaths. There were 70 preoperative noncardiac mor-
idities in 49 patients, and 140 preoperative cardiac morbidities
n 78 patients. Preoperative arrhythmia and moderate to
reater systolic dysfunction were most common. There were
1 postoperative adverse noncardiac events in 32 patients.
enal insufficiency was most common. There were 53
ostoperative adverse cardiac events in 44 patients, ventric-
lar tachycardia in 13 patients being most common. Risk
actors for adverse postoperative noncardiac events included
reoperative histories of New York Heart Association
unctional class III or greater and psychiatric disorder. Risk
actors for postoperative adverse cardiac events included
lder patient age, preoperative functional single ventricle,
ew York Heart Association functional class III or greater, pnd atrial fibrillation/flutter and ventricular tachycardia or
brillation. Postoperative adverse events occurred frequently
hen adults undergo cardiac operations. Many patients with
omplex congenital cardiac conditions are now best served
t children’s hospitals because of the expertise of the
urgeon, intensive care unit, and CHD team of specialists.
dult problems that are not familiar to pediatric specialists
ill occur in many of these patients, and their postoperative
are eventually will be best served by those with both
ediatric and adult training in CHD and with expertise in
dult cardiac and noncardiac disease. This again emphasizes
he need for development of adult cardiologists with special
xperience and expertise in CHD.
enetic Issues
olan et al. (43) reported on prospective and retrospective
ata of children diagnosed with hypertrophic cardiomyop-
thy (HCM). Of 855 patients 18 years old with HCM,
.7% had inborn errors of metabolism, 9.0% had malfor-
ation syndromes, 7.5% had neuromuscular disorders, and
4% had idiopathic HCM. Children with HCM associated
ith inborn errors of metabolism and malformation syn-
romes have significantly worse survival. Patients with
diopathic HCM diagnosed before 1 year of age had worse
urvival from the time of diagnosis than those diagnosed
fter 1 year of age. Patients with idiopathic HCM who
urvive to at least 1 year of age have an annual mortality rate
f 1% regardless of whether they were diagnosed before or
fter 1 year of age. Patients presenting before 1 year of age
ave the broadest spectrum of causes and the poorest
utcomes. The annual mortality rate of 1% for children is
uch lower than previously reported in children and is not
ifferent from adults. These data are useful in caring for
ediatric and young adult patients with HCM. Risk man-
gement and stratification of patient therapy including ICD
se remains a difficult task.
Arnestad et al. (44) reported on the prevalence of long
T syndrome gene variants in sudden infant death syn-
rome. Mutations and rare variants were found in 26 of 201
ases or 13%. On the basis of their functional effect, the
nvestigators considered that 8 mutations and 7 rare variants
ound in 19 of 201 cases likely contributed to 9.5% of
eaths. Sudden arrhythmic death is an important contrib-
tor to sudden infant death syndrome.
iscellaneous
heung et al. (45) reported on a randomized, controlled
rial of the effects of remote ischemic preconditioning in
hildren undergoing cardiac surgery. Thirty-seven patients
ere studied, with 20 control patients and 17 patients in the
nvestigational group. Bypass and cross-clamp times were
ot different. Levels of troponin I postoperatively were
reater in the control patients than in the preconditioned
roup, and inotropic requirement also was greater in control
atients at 3 and 6 h. This study shows the myocardial
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Year in Congenital Heart Disease July 24, 2007:368–77rotective effects of ischemic preconditioning using a sim-
le, noninvasive technique of 5-min cycles of lower limb
schemia and reperfusion. These novel data support the
eed for a larger study of remote ischemic preconditioning.
Mildh et al. (46) reported on cardiac troponin T levels for
isk stratification in pediatric heart surgery. Data were
btained on 1,001 children over the course of 5 years. Level
f troponin T 5.9 mg/l on the first postoperative day
redicted death (odds ratio 10.7), as did admission lactate
evel 5.2. No other variables had any independent effect
n 30-day survival. Troponin T level on the first postoper-
tive day is a powerful risk marker of death. This measure-
ent can be used to stratify patients and emphasizes the
eed for improved myocardial protection techniques during
urgery.
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